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Growth retarded fetuses and neonates have higher
morbidity and mortality rates than normally devel-
oped infants of comparable age [4, 5, 16, 19, 20,
24]. During the immediate neonatal period, small-
for-date infants run an increased risk of infection,
are particularly prone to hypoglycemia and have
difficulties in maintaining normal body tempera-
ture. Subsequently some of these infants will not
attain normal body size, and a considerable num-
ber will suffer from neurologic impairment [8,10,
23].
Early detection of intrauterine growth retardation
(IUGR) and careful monitoring of the affected
fetuses, both by biophysical and biochemical
means, are of substantial interest to the obstetri-
cian. Once fetal growth retardation is recognized,
the obstetrician will attempt to normalize fetal
growth during the further course of the pregnancy
by elimination of maternal causes contributing to
the gestational disorder (nicotine, drug abuse,
maternal malnutrition, etc.) or by intensive ther-
apy of accompanying maternal complications
(toxemia, gestational diabetes, etc?) In some cases,
early delivery of a viable fetus will be accom-
plished before irreversible damage or death has
occurred.
During the 2nd and 3rd trimester of pregnancy,
the major proportion of estriol circulating in
maternal blood and being excreted through mater-
nal urine and feces is synthesized in the feto-
placental unit [6, 7]. Normal maternal plasma
estriol levels indicate fetal well-being, whereas
abnormal estriol profiles are mostly associated
with abnormal fetal development or fetal distress
[14].
The study was designed to examine the possibil-
ities of predicting fetal growth retardation äs
early äs during the 2nd trimester of pregnancy by
means of total and unconjugated estriol assay in
maternal plasma and to compare the usefulness of
these two feto-placental function tests in the ante-
partum Identification of growth retardation.
l Patients and materials
In 583 pregnancies at 15 to 42 gestational weeks,
913 plasma samples of peripheral maternal venous
blood were assayed for their concentrations of
total estriol and unconjugated estriol.
Among the pregnancies examined there were 463
mothers who were delivered of a healthy singleton
infant of normal birthweight. These women con-
tributed 707 plasma samples to this study. Normal
birthweight was defined äs being between the lOth
and 90th percentiles for gestational age according
to the birthweight curves of NICKL [25], which
describe the relative frequency of birthweights by
week of gestation for the German population in
the 1960s. Gestational age was determined by the
clinical criteria proposed by FARR [9] and PE-
TRUSSA [26] which are based upon estimations of
neonatal maturity.
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described. The extraction yield amounted to 98.1
± 1.2% äs measured by the recovery of known
quantities of tritium-labelled estriol.
Estriol quantitation was carried out by means of a
radioimmunoassay which followed in essence the
procedure described by TULCHINSKY and ABRA-
HAM [29]. The estriol extracted was incubated
with estriol antiserum and labelled estriol in
0.04 M phosphate buffer pH 7.4 with 0.1% bovine
serum albumin added at 0° to 4 °C for 120 min-
utes. Unbound estriol was then separated from
antiserum bound estriol by the addition of a char-
coal/dextran Suspension (l mg charcoal per tube).
After centrifugation the radioactivity of the super-
natant was measured in a liquid scintillation
counter. The estriol concentrations of the samples
assayed were calculated using a special Computer
program.
The estriol antiserum used was raised in rabbits
through repeated injections of a conjugate of
estriol-6-(0-carboxymethyl)oxim with BSA äs
immunogen (SORIN BIOMEDICA, Saluggia, Italy).
This antiserum had a cross-reaction of 0.01% with
estradiol and 0.001% with estrone at 50% displace-
ment. As tracer 2,4,6,7-3H-(N) estriol was used up
to 0.5 (18.5 KBq) for 100 samples.
In the ränge of 10 and 100 pg estriol per RIA
tube, the intra-assay and inter-assay Variation
coefficients were 5.1% and 6.9%. Using the RIA
System, the lowest detectable amount of estriol
was 6 ± 2 pg. The recovery of known estriol
amounts added to plasma samples was at 96%
nearly quantitative.
2 Results and comments
2.1 Total estriol in pregnancies
with normal outcome
Tab. III and Fig. l show the total estriol concen-
trations (conjugated plus unconjugated steroid) in
maternal plasma related to gestational age for the
Fig. 1. Percentile curves of total estriol in maternal plasma
related to gestational age in pregnancies with healthy, nor-
mal weight infants.
Tab. III. Means, medians, 95% and 70% confidence limits, and ranges of total estriol determined in 707 maternal
plasma samples from 463 pregnancies with normal weight, healthy neonates. 95% confidence limits = between 2.5th
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pregnancies with normal weight and healthy out-
come. Taken äs a whole, the values were similar to
the reference values recently reported by FRE-
SINSKY, CASTANIER, GRENIER and SCHOLLER
[11]. Due to the fact that there were asymmetrical
distributions of the hormone concentrations, the
estriol figures were represented äs percentiles. As
values of comparison to the medians, the appro-
priate arithemetical means were given in the estriol
tabulation. The median total estriol concentrations
were in general slightly lower than their means,
indicating a denser aggregation of the estriol values
below the means than above them. Commencing
with the gestational weeks 35 to 36, the well-
known steep rise in total estriol concentrations
could be noticed. This was associated with a wide
scatter of single values up to and above 400 ng/ml.
15 17 19
Gestational weeks
Fig. 2. Percentile curves of unconjugated estriol in mater-
nal plasma related to gestational age in pregnancies with
healthy, normal weight infants.
The 15th percentiles for total plasma estriol which
were used äs thresholds i« the characterization of
abnormally low steroid levels and äs upper screen-
ing limits of a fetal danger zone, showed a marked
increase from 5 to 21 ng/ml early in the 2nd tri-
mester. They then lay between 25 and 40 ng/ml in
the gestational weeks 25 to 32, and rose to values
of approximately 45 to 65 ng/ml between weeks
33 and 38. Later on, the 15th percentiles of total
plasma estriol varied between 85 and 95 ng/ml.
2.2 Unconjugated estriol in pregnancies
with normal outcome
Tab. IV and Fig. 2 show the unconjugated estriol
concentrations in mäternal plasma related to gesta-
tional age. By comparison of Fig. l and 2 one may
easily recognize that there was a close parallel in
the shape of the curve äscents for unconjugated
and total plasma estriol during the second and
third trimester, with the average proportion of un-
conjugated "estriol varying between 6 and 8% of
total estriol. The above^mentioned steep rise of
total plasma estriol at gestational weeks 35 to 36
with an associated very wide scatter of some
individual values also occurred in the unconjugated
estriol fraction.
The 15th percentiles for unconjugated estriol in
mäternal plasma rose steeply from 0.3 to 1.7 ng/ml
between gestational weeks 15 and 24. During the
Tab. IV. Means, medians, 95% and 70% confidence limits, and ränges of uncorijugated estriol in maternal pfasma from
the pregnancies with normal weight, healthy neonates.
Gestational weeks Number of Unconjugated estriol (ng/ml)
plasmas
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weeks 25 to 32 they were 2.1 to 3.4 ng/ml; in the
weeks 33 to 38, 3.8 to 4.5 ng/ml; and 5.3 to
5.6 ng/ml during the last four gestational weeks.
2.3 Total estriol in pregnancies
with intrauterine growth retardation
Tab. V shows the total estriol concentrations in
maternal plasma related to gestational age for the
pregnancies with small-for-date babies. From com-
parison of these values with those in pregnancies
with normal outcome, it becomes clear that IUGR
was associated with low concentrations of mater-
nal plasma estriol, both in the 2nd and in the 3rd
trimester. The total estriol medians in the IUGR
group lay, with the exception of two values during
early 2nd trimester, below those in the reference
group. The values strongly diverged especially
during the last 6 to 8 weeks of gestation. In this
period, the total estriol median curve of the IUGR
group lacked the characteristic accelerated increase
to be found in the group of pregnancies with
normal outcome (Fig. 3).
The absolute and relative distribution of the in-
dividual total estriol concentrations measured in
the IUGR group within the above-described estriol
percentiles System from the pregnancies with
normal outcome is represented in Tab. VII. In the
IUGR group (gestational weeks 15 to 42) 36.40%
(14.56% plus 21.84%) of total estriol values
moved below the 15th total estriol percentile of
the reference group with normal outcome. Re-
markably, during the 3rd trimester (gestational
weeks 29 to 42) the relative frequency of total
estriol values from the IUGR group below the
15th reference estriol percentile was 41.27%
(16.67% plus 24.60%); whereas, during the 2nd
trimester (gestational weeks 15 to 28), it was only
28.75 % (l l .25 % plus 17.50%) (Tab. VII).
Fig. 3. Medians of total estriol levels in maternal plasma
from 120 pregnancies with intrauterine growth retarda-
tion Qower solid line) and 463 pregnancies with normal
outcome (upper broken line). Note the remarkably low
total estriol increase in the group of intrauterine growth
retardation following gestational week 30.
Tab. V. Means, medians, 95% and 70% confidence limits, and ranges of total estriol determined in 206 maternal plasma
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2.4 Unconjugated estriol in pregnancies
with intrauterine growth retardation
The concentrations of unconjugated estriol in
maternal plasma from pregnancies with IUGR
showed a rather similar trend towards their total
estriol counterparts. They were substantially lower
in almost all gestational weeks of the 2nd and 3rd
trimester compared with their reference val es of
the normal outcome group (Tab. VI). The uncon-
jugated estriol medians of the IUGR group lay,
with the exception of one value in the early 2nd
trimester, always below those f the normal out-
come group. As early s the 2nd trimester the
divergence of the two median curves was very
clear, while in the 3rd trimester it did not appear
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Fig. 4. Medians of unconjugated estriol levels in maternal
plasma. Same patients s represented in Fig. 3. Lower
solid line = IUGR pregnancies, upper broken line = preg-
nancies with normal outcome.
As can be seen from Tab. VI, VII, in the IUGR
group 38.83% of unconjugated estriol val es
(1 1.65% plus 27.18%) could be detected below the
15th estriol reference percentiles (gestational
weeks 15 to 42), while the corresponding value for
total estriol was 36.4% (no statistically significant
difference between the two val es).
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During the 2nd trimester the relative frequency of
unconjugated estriol values in the IUGR group
encountered below the 15th estriol reference
percentile was 46.25% (17.50% plus 28.75%).
This is in contrast to only 34.13% during the 3rd
trimester (7.94% plus 26.19%); (Tab. VII).
2.5 Total and unconjugated estriol in pregnancies
with intrauterine growth retardation
Fig. 5 demonstrates that in the course of the 2nd
s well s of the 3rd trimester both total and un-
conjugated plasma estriol levels were significantly
lower in the IUGR group compared with the
estriol levels in the group with normal outcome.
Separate evaluations of total and unconjugated
estriol concentrations in women with severe or
mild forms of fetal growth retardation (infants
below the 3rd or the lOth birthweight percentiles)
did not reveal any clear differences between the
Fig. S. Paircd total estriol and unconjugated estriol levels
(mean ± S.E.M.) in maternal plasma determined in the
gestational wceks 19 to 20 and 37 to 38 in women with a
normal or growth retarded fetus. Pregnancies with a
growth retarded fetus have significantly lower total and
unconjugated estriol levels (χ -test) both in the 2nd and
in the 3rd trimester, compared with the estriol leveis in
















































Normal (n =60) IUGR (n=17) Normal (n -95) IUGR (n=30)
Gest. weeks 19-20 Gest. weeks 37-38
Tab. VI. Means, medians, 95% and 70% confidence limits, and ranges of unconjugated estriol determined in 206 mater-
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hormone levels in the two weight categories of
IUGR pregnancies. Nor did the estriol levels from
pregnancies with "pure" IUGR or IUGR asso-
ciated with toxemia characteristically differ from
each other.
The failure of serial low plasma estriol levels to
show the characteristic rise which is commonly
observed during the 3rd trimester of pregnancies
with normal outcome was described by KLOPPER,
JANDIAL and WILSON [21] äs a reliable sign of
intrauterine growth retardation. Fig. 6 shows that
a similar plasma estriol conduct may be seen al-
ready during the 2nd trimester öf pregnancies with
IUGR.
17 18 19 20 21 22 23 24 25 26 27 28
Fig. 6. Serial low unconjugated plasma estriol levels with
reduced rising tendency (solid line) during the 2nd tri-
mester in a 42 year-old women with a growth retarded
fetus. At gestational week 38 delivery of a male infant of
2680 g in good health. - Broken lines = 2.5th and 50th
unconjugated estriol percentiles in the group of preg-
nancies with normal outcome.
3 Discussion
The paired hormone assays demonstrated that
both total estriol and unconjugated estriol con-
centrations in maternal plasma tended to be low in
pregnancies with intrauterine growth retardation.
Under the premise that the 15th percentiles of
maternal plasma estriol concentrations in preg-
nancies with normal outcome were used äs screen-
ing limits, 36.40% of the blood specimens from
IUGR pregnancies had abnormally low concentra-
tions of total estriol, and 38.83% of them had
abnormally low concentrations of unconjugated
estriol in the course of the 2nd and 3rd trimester.
In the 2nd trimester the predictive value for IUGR
of unconjugated plasma estriol was higher than
that of total plasma estriol. In the 3rd trimester
the Situation was reversed. A clear superiority in
predicting IUGR by unconjugated plasma estriol
(in comparison with total plasma estriol), äs has
been claimed on theoretical considerations by
some authors [30], could not be confirmed in this
study.
The prediction of fetal growth retardation by
plasma estriol estimations could be made with a
similar degree of probability during the 2nd tri-
mester äs during the 3rd; an observation that may
attract the attention of the obstetrician and per-
haps of the perinatologic pathologist, since it
sheds some light on the early onset of this gesta-
tional complication.
Studies of plasma estriol with the aim of predect-
ing or monitoring intrauterine growth retardation
have been condücted repeatedly [l, 3,12,15,17,
18, 21, 22]. All the$e üivestigations, which dealt
almost entirely with IUGR cases in late pregnancy,
led to the unequivocal conclusion that in preg-
nancies with retarded fetal growth the maternal
estriol values were commonly lower than normal
and that the estriol curves obtained by serial
plasma estriol measurements were flattened in
comparison with those in pregnancies of com-
parable gestational age with normal outcome.
Less unanimity among the authors existed äs to
the rate of true IUGR prediction by plasma estriol.
The quotation of accurate predictions by plasma
estriol assays ranged from 20% reported by Tow-
LER et al. [28] to an astonishingly high 86% re-
ported by GOEBEL et al. [13] in cases of IUGR
without hypertension. Evidently some of the dis-
crepancies in the assessment of the predictive valüe
of plasma estriol measurements were due to appli-
cation of different criteria in defining abnormally
low estriol levels or birthweight limits for small-
for-dates infants or the use of different hormone
assay procedures.
Between the plasma estriol concentrations in
pregnancies with normal outcome and those with
IUGR there was a large area of overlapping, a fact
which logically limits the diagnostic usefulness of
the measurements. It presently often remains
obscure why in one individual case of IUGR the
classical low estriol values are found and in another
case they are not. In this connection one should
J. Perinät. Med. 10 (1982)
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keep in mind that the clinical syndrome of intrau-
terine growth retardation can result from diseases
of the mother, the placenta and the fetus, or from
special circumstances relating to genetics or mater-
nal environmental setting.
Taking these various roots of IUGR into considera-
tion, it should not be surprising that only a pro-
portion of all IUGR cases can be discovered by
feto-placental function tests such äs maternal
plasma estriol assay. For example, in a pregnancy
complicated by ample placental infarcts and a
substantial reduction in maternal-placental Sub-
strate and gas exchange, the investigator may
easily find retarded fetal growth associated with
abnormally low plasma estriol levels. On the other
hand, a pregnant woman who is a severely un-
dernourished drug user with a growth retarded
fetus may have normal plasma estriol levels.
In the 2nd and 3rd trimester of gestation maternal
plasma estriol is almost entirely a product of the
conceptus. Being synthesized by complementary
steroidogenic mechanisms in the fetus and pla-
centa, estriol is released from the circulation of the
conceptus into the circulation of the pregnant wo-
Summaiy
In 913 plasma samples collected from 583 mothers in the
2nd and 3rd trimester of pregnancy (gestational weeks 15
to 42), paired determinations of total and unconjugated
estriol levels were performed by radioimmunoassay. 707
of the samples were taken from 463 mothers who were
delivered of healthy singleton normal birthweight infants.
The remaining 206 plasmas assayed came from 120 preg-
nant women who gave birth to singleton small^for-date
infants whose birthweight feil below the lOth percentile
for gestational age and who were therefore classified äs
suffering from intrauterine growth retardation (IUGR).
From the levels encounteied in the pregnancies with
normal weight outcome, reference values such äs medians,
means, 95% and 70% confidence limits of total and un-
conjugated plasma estriol were calculated for the 2nd and
3rd trimester. Due to the asymmetrical distribütion of the
estriol data, their mathemätical representation was pre-
dominantly done in percentiles. Values which feil below
the 15th plasma estriol percentile for gestational age were
regarded äs abnormally low and indicators of .„Potential
fetal danger.
In pregnancies with IUGR, total and unconjugated estriol
in maternal plasma tended to be lower than in pregnancies
with normal weight offspring. The medians of total and
unconjugated plasma estriol from the IUGR group lay
man. Regulär feto-placental synthesis of estriol
requires a sufficient supply of oxygen and steroidal
precursors; thus, plasma estriol assays may be used
in the assessment of feto-placental function during
the 2nd and 3rd trimester of pregnancy [6], Nor-
mal maternl plasma estriol concentrations with a
rising tendency in the progression of gestation
indicate good outcome.
Since plasma estriol measurements can now be
carried out readily, precisely, repeatedly and with-
out major molestation to the mother, they are a
valuable tool in monitoring and managing preg-
nancies with chronic complications such äs intrau-
terine growth retardation, placental insufficiency
or postmaturity. Assays of total estriol in amniotic
fluid seem to be superior to maternal plasma
estriol assays in predicting IUGR in late gestation
[2]. Of course, the combined application of differ-
ent clinical tests such äs ultrasonography, fetal
heart monitoring, HPL assays, total estriol, lecithin
determinations in amniotic fluid and plasma estriol
assays will provide the obstetrician engaged in the
management of an IUGR pregnancy with much
more useful data than would be obtained with an
estriol determination alone.
usually below those from the normal birthweight refer-
ence group. During the third trimester the rate of ab-
normally low total estriol levels from the IUGR group
amounted to 41%, while that of abnormally low un-
conjugated estriol levels was 34%. During the second tri-
mester 29% of the total estriol values and 46% of the un-
conjugated estriol values from the IUGR group feil below
the corresponding 15th estriol percentiles. Generally, the
rate of abnormally low maternal plasma estriol levels
from the IUGR group in the 2nd and 3rd trimester was
almost identical — between 35% and 40% — for the total
and the unconjugated estriol.
Three riiain conclusions could be drawn from this study:
1. Measurements of total and unconjugated estriol in
maternal venous plasma during the 2nd and 3rd trimester
of pregnancy were of comparable clinical usefulness. The
overäll effiäency of the two estriol tests in discriminating
pregnancies with IUGR was 36% for total estriol and
38% for unconjugated estriol. 2. Predictions of IUGR by
abnormally low plasma estriol levels could be made with
a similar rate of accuracy both during the 2nd and 3rd
trimester. 3. Plasma estriol determinations appeared to be
most useful when normal estriol results provided some
reassurance to the obstetrician that the current Status of
the fetus was satisfactory.
Keywords: Birthweight, intrauterine growth retardation, maternal plasma, monitoring of pregnancy, total estriol, un-
conjugated estriol.
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Zusammenfassung
Paarige Bestimmungen des Gesamtöstriols und unkonju-
gierten Östriols im mütterlichen Plasma im 2. und 3. Tri-
menon - Ihre Beziehung zur intrauterinen Wachstums
letardierung
In 913 Plasmaproben von 583 Müttern im 2. und 3. Tri-
menon (Schwangerschaftswochen 15 bis 42) wurden paa-
rige RIA-Bestimmungen von Gesamt- und unkonjugiertem
Östriol vorgenommen. 707 Proben stammten von 463
Müttern, die von gesunden, normal wiegenden Kindern
entbunden wurden. Die übrigen 206 untersuchten Plas-
men waren von 120 Schwangeren, die small-for-date Kin-
der gebaien, deren Geburtsgewicht unterhalb der dem
Schwangerschaftsalter entsprechenden 10. Perzentile lag
und die deshalb als Kinder mit intrauteriner Wachstums-
retardierung klassifiziert wurden.
Aus den Hormonwerten der Schwangerschaften mit nor-
mal wiegenden Kindern wurden Referenzwerte berechnet,
d.h. Mediane, Mittelwerte, 95% und 70% Vertrauensbe-
reiche von Gesamt- und unkonjugiertem Östriol für das
2. und 3. Trimenon. Wegen der asymmetrischen Vertei-
lung der Werte erfolgte ihre mathematische Darstellung
vorwiegend in Perzentilen. Werte, die sich unterhalb der
dem Schwangerschaftsalter entsprechenden 15. Plasma-
östriol-Perzentile bewegten, wurden als abnorm niedrig
angesehen und als Hinweiszeichen potentieller Gefähr-
dung des Feten gewertet.
In Schwangerschaften mit intrauteriner Wachstumsretar-
dierung tendierten Gesamtöstriol und unkonjugiertes
Östriol im mütterlichen Plasma zu niedrigeren Werten als
in Schwangerschaften mit normal wiegender Nachkom-
menschaft. Die Östriol-Mediane der Schwangerschaften
mit intrauteriner Wachstumsretardierung lagen gewöhn-
lich unter den Östriol-Medianen der Schwangerschaften
mit normalem Geburtsgewicht der Kinder. Während des
3. Trimenons betrug der Anteil der abnorm niedrigen Ge-
samtöstriol-Werte bei den Schwangerschaften mit intrau-
teriner Wachstumsretardierung 41%, während der Anteil
der abnorm niedrigen Werte für unkonjugiertes Östriol
34% ausmachte. Während des 2. Trimenons lagen 29% der
Gesamtöstriol-Werte und 46% der Werte für unkonjugier-
tes Östriol in der Gruppe der Schwangerschaften mit in-
trauteriner Wachstumsretardierung unter den entsprechen-
den 15. Östriol-Perzentilen der Referenzgruppe. Betrach-
tete man die Östriol-Werte aus dem 2. und 3. Trimenon
gemeinsam, dann war der Anteil von abnorm niedrigen
Östriol-Werten in der Gruppe der Schwangerschaften mit
intrauteriner Wachstumsretardierung für Gesamtöstriol
und unkonjugiertes Östriol nahezu identisch (zwischen
35% und 40%).
Drei hauptsächliche Schlußfolgerungen wurden aus der
vorliegenden Studie gezogen: 1) Bestimmungen von
Gesamtöstriol und unkonjugiertem Östriol im mütterli-
chen venösen Plasma waren während des 2. und 3. Tri-
menons von vergleichbarem klinischem Nutzen. Bei der
Abgrenzung von Schwangerschaften mit intrauteriner
Wachstumsretardierung betrug die Gesamttrefferquote
der zwei Östrioltests 36% für Gesamtöstriol und 38% für
unkonjugiertes Östriol im Plasma. 2) Vorhersagen von
intrauteriner Wachstumsretardierung ließen sich aufgrund
von abnorm niedrigen Östriolkonzentrationen im mütter-
lichen Plasma sowohl im 2. wie auch im 3. Trimenon mit
ähnlicher Trefferquote machen. 3) Östriolbestimmungen
im mütterlichen Plasma schienen sehr nützlich zu sein,
wenn die normalen Östriol-Werte dem Geburtsmediziner
einige Sicherheit vermittelten, daß der aktuelle Zustand
des Fetens zufriedenstellend war.
i H
··
Schlüsselwörter: Geburtsgewicht, Gesamtöstriol, intrauterine Wachstumsretardierung, mütterliches Plasma, Schwanger-
schaftsüberwachung, unkonjugiertes Östriol.
Resume
Determinations couplees de Festriol plasmatique maternel
total et non conjugue pendant le deuxieme et le troisieme
trimestre de la grossesse - Relations avec le retard de
croissance intra-uterin
Les dosages couples de Festriol total et de l'estriol non
conjugu6 ont ete realises par radio-immunologie sur 913
plasma de 583 meres au couis du 2eme et 3eme trimestre
de la grossesse (15eme a 42eme semaines gestation-
nelles) - 707 echantfflons plasmatiques ont ete preleves
chez 463 meres ayant accouche d'enfants uniques de
poids de naissance normal et en bonne sante. Les 206
restants ont ete preleves chez 120 femmes enceintes ayant
accouche d'enfants uniques hypotrophiques avec un poids
de naissance inferieur au dixieme percentile pour Tage
gestationnel et ainsi consideres comme ayant subi un
retard de croissance intra-uterin (RCIU).
A partir des resultats obtenus pour les grossesses ayant
abouti a un nouveau-ne de poids normal, on a calcule des
valeurs de reference telles que les moyennes, la validite,
les intervalles de confiance a 95 % et 70%, pour les estriols
totaux et les estriols non conjugues au second et au
troisieme trimestre. En raison de la distribution
asymetrique des resultats, leur expression mathematique
a ete effectuee essentiellement en percentiles. Les valeurs
situees sous le 15eme percentile de Festriol plasmatique
pour Tage gestationnel ont ete considerees comme
anormalement basses et comme indicatrices de danger
potentiel pour le foetus.
Lors des grossesses avec RCIU, l'estriol plasmatique
maternel total et non conjugue tend ä etre plus bas que
lors des grossesses ayant abouti a un enfant de poids
normal. Les moyennes d'estriol plasmatique total et non
conjugue dans le groupe avec RCIU sont en regle inferi-
eures a celles du groupe de reference sans hypothrophie.
Pendant le troisieme trimestre le taux d'estriol total
anormalement bas est de 41% dans le groupe avec RCIU,
alors que le taux d'estriol total non conjugue est de 34%.
Pendant le second trimestre, 29% des valeurs de l'estriol
total et 46% des valeurs de Festriol non conjugues sont
atues sous le 15eme percentile dans le groupe avec RCIU.
Globalement, la frequence de taux d'estriol anormalement
bas dans le groupe avec RCIU pendant le 2eme et le 3eme
trimestre est ä peut pres la meme — entre 35 et 40% —
pour Festriol plasmatique maternel total et pour Festriol
non conjugue.
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On peut tirer trois conclusions principales de ce travail:
1. les dosages de Pestriol plasmatique maternel total et de
l'estriol non conjugue revetent une utilite clinique
comparable pendant le 2&me et le 3&me trimestre.
L'efficacite globale des deux dosages poui determiner les
grossesses avec RCIU est de 36% pour l'estiiol total et de
38% poui l'estriol non conjugue. 2. La prevision du RCIU
par la determination de taux d'estriols plasmatiques
anormalement bas peut etre portee avec une fiabilite
identique pendant le second et le troistöme trimestre.
3. Cest lorsque les resultats sont normaux que les
dosages de l'estriol plasmatique revetent la plus grande
utilite en assuiant quelque peu aux obstetriciens que
l'etat actuel du foetus est satisfaisant.
Mots-cles: Estriol non conjugue, estriol total, hypotrophie, plasma maternel, poids de naissance, surveillance de la
: grossesse.
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